Skip to main content
. Author manuscript; available in PMC: 2010 Nov 1.
Published in final edited form as: J Antibiot (Tokyo). 2010 Mar 26;63(5):219–224. doi: 10.1038/ja.2010.22

Figure 3.

Figure 3

In vivo efficacy of etamycin in a murine model of MRSA sepsis. Eight week old female CD1 mice were injected intraperitoneally with 2 × 109 colony-forming units of HA-MRSA strain Sanger 252 in 1% mucin. At one and eight hours after infection (indicated by arrows), the mice were injected intraperitoneally with either 20 mg/kg etamycin (n = 10) or DMSO vehicle control (n = 8). The mice were monitored for signs of sepsis for up to 72 hours, and mice that became moribund were humanely euthanized.